https://www.selleckchem.com/products/glesatinib.html WAY100635 antagonized the 8-OH-DPAT-induced decrease in 5-HT levels. In SERT-KO mice, 8-OH-DPAT did not decrease 5-HT levels in the striatum and PFC. 5-MeO-DIPT dose-dependently increased DA levels in the PFC, but not striatum, in wildtype and SERT-KO mice. The increase in DA levels that was induced by 5-MeO-DIPT was not antagonized by WAY100635. 5-MeO-DIPT influences both 5-HT and DA levels in the striatum and PFC. 5-MeO-DIPT dually acts on SERT and 5-HT receptors so that elevations in 5-HT levels produced by reuptake inhibition are limited by actions of the drug on 5-HT receptors. 5-MeO-DIPT influences both 5-HTex and DAex levels in the striatum and PFC. 5-MeO-DIPT dually acts on SERT and 5-HT1A receptors so that elevations in 5-HTex levels produced by reuptake inhibition are limited by actions of the drug on 5-HT1A receptors. T helper 17 (Th17) cells are a subset of CD4 T cells that produce interleukin (IL)-17A. Recent studies showed that an increase in circulating IL-17A causes cognitive dysfunction, although it is unknown how increased systemic IL-17A affects brain function. Using transgenic mice overexpressing RORγt, a transcription factor essential for differentiation of Th17 cells (RORγt Tg mice), we examined changes in the brain caused by chronically increased IL-17A resulting from excessive activation of Th17 cells. RORγt Tg mice exhibited elevated Rorc and IL-17A mRNA expression in the colon, as well as a chronic increase in circulating IL-17A. We found that the immunoreactivity of Iba1 and density of microglia were lower in the dentate gyrus of RORγt Tg mice compared with wild-type mice. However, GFAP astrocytes were unchanged in the hippocampi of RORγt Tg mice. Levels of synaptic proteins were not significantly different between RORγt Tg and wild-type mouse brains. In addition, novel object location test results indicated no difference in preference between these mice. Our findings indicate that a con